Clinical Trial Update: Phase 1 Study for IPG11406 in Health Volunteer [Phase 1]

View source ↗

Summary

Phase 1 study of IPG11406 completed in healthy volunteers; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• IPG11406

Snippet

Sponsor: Nanjing Immunophage Biotech Co., Ltd | Conditions: Inflammatory Bowel Diseases | Phase 1 | Status: COMPLETED | Results posted: 2026-04-17